| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1462 | 2021 |
| Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer S Awad, BH Tan, H Cui, A Bhalla, KCH Fearon, SL Parsons, JA Catton, ... Clinical nutrition 31 (1), 74-77, 2012 | 289 | 2012 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 221 | 2022 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 111 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 76 | 2022 |
| The preoperative assessment and optimization of patients undergoing major urological surgery HW Cui, BW Turney, J Griffiths Current Urology Reports 18, 1-10, 2017 | 50 | 2017 |
| Smartphone apps for urolithiasis DJ Stevens, K McKenzie, HW Cui, JG Noble, BW Turney Urolithiasis 43, 13-19, 2015 | 46 | 2015 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 45 | 2022 |
| CT Texture Analysis of Ex Vivo Renal Stones Predicts Ease of Fragmentation with Shockwave Lithotripsy HW Cui, W Devlies, S Ravenscroft, H Heers, AJ Freidin, RO Cleveland, ... Journal of endourology 31 (7), 694-700, 2017 | 25 | 2017 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 16 | 2023 |
| Predicting shockwave lithotripsy outcome for urolithiasis using clinical and stone computed tomography texture analysis variables HW Cui, MD Silva, AW Mills, BV North, BW Turney Scientific Reports 9 (1), 14674, 2019 | 16 | 2019 |
| Efficacy of the lithotripsy in treating lower pole renal stones H Cui, E Thomee, JG Noble, JM Reynard, BW Turney Urolithiasis 41 (3), 231-234, 2013 | 15 | 2013 |
| The utility of automated volume analysis of renal stones before and after shockwave lithotripsy treatment HW Cui, TK Tan, FE Christiansen, PJS Osther, BW Turney Urolithiasis 49 (3), 219-226, 2021 | 10 | 2021 |
| Utility of blood tests in screening for metabolic disorders in kidney stone disease KS Eyre, F Lewis, H Cui, E Grout, R Mihai, BW Turney, SA Howles BJU international 127 (5), 538-543, 2021 | 10 | 2021 |
| The association of pre‐operative home accelerometry with cardiopulmonary exercise variables HW Cui, GS Kirby, K Surmacz, C Hargrove, J Griffiths, BW Turney Anaesthesia 73 (6), 738-745, 2018 | 10 | 2018 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 8 | 2023 |
| Impact of COVID‐19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study MHV Byrne, F Georgiades, A Light, CE Lovegrove, C Dominic, J Rahman, ... BJU international 131 (1), 82-89, 2023 | 8 | 2023 |
| Surveillance for low-risk kidney cancer: a narrative review of contemporary worldwide practices HW Cui, ME Sullivan Translational Andrology and Urology 10 (6), 2762, 2021 | 4 | 2021 |
| 464 Predicting successful shockwave lithotripsy using CT texture analysis: A potential novel biomarker H Cui, D Stevens, B Ganeshan, B Turney European Urology Supplements 3 (15), e464, 2016 | 2 | 2016 |
| A new cancer on the block: Tuberous sclerosis-associated renal cell carcinoma H Cui, C Verrill, M Sullivan Journal of Clinical Urology 16 (1), 75-80, 2023 | 1 | 2023 |
